IHS Chemical Week

World News and Views :: Top of the News

Merck & Co. Buys Back its Riverside Pharmaceutical Intermediates Plant

1:34 AM MDT | August 11, 2010 | Natasha Alperowicz

Merck & Co. says it will buy back its Riverside, PA pharmaceutical ingedients plant from PRWT Services (Philadelphia), a company that acquired the facility from Merck in 2008. Cherokee Pharmaceuticals, a wholly owned subsidiary of PRWT, is the operator of the plant. The company took over the unit at a time when major drug firms were increasingly outsourcing pharmaceutical ingredients manufacturing to save costs. The plant makes intermediate compounds for two antibiotics, Invanz and Primaxin. It also makes Merck's cholesterol drug, MK524, and Avermectin, an...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa